Date

23 January 2018

New Index Rates Drug Companies in Fight Against ‘Superbugs’

Donald McNeil of The New York Times reports on the results of the Antimicrobial Resistance Benchmark and the companies who are tackling the growing “superbug” threat.

Donald McNeil’s article covers the criteria used to analyse companies’ contributions to preventing the spread of bacteria that are resistant to antibiotics. It also focuses on the importance of having new antibiotics in development.